Praveen R Srinivasan

Therapeutic targeting of TRAIL death receptors

Lanlan Zhou, A. Seyhan, B. Carneiro, 2023, Biochemical Society transactions.

The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies

Paul Bertone, W. El-Deiry, B. Carneiro, 2021, American journal of clinical oncology.

Combination of 5-FU plus KRAS G12D inhibitor MRTX1133 against human colorectal and pancreatic cancer cells and the affects on inhibition of pERK and immune-stimulatory cytokine patterns in in KRAS G12D and KRAS G12V tumor cells.

Lanlan Zhou, K. Huntington, W. El-Deiry, 2023, Journal of Clinical Oncology.

GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer

Brittany A. Borden, M. Dooner, Lanlan Zhou, 2023, International journal of molecular sciences.

GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer

Brittany A. Borden, M. Dooner, Lanlan Zhou, 2023, bioRxiv.

A rapid screening assay for antioxidant potential of natural and synthetic agents in vitro.

Ramesh C. Gupta, M. Vadhanam, J. Arif, 2002, International journal of oncology.

Targeting apoptotic pathways for cancer therapy

Shengliang Zhang, Lanlan Zhou, A. Seyhan, 2024, The Journal of clinical investigation.

ITGB6 inhibition stimulates anti-tumor responses in immunocompetent mouse models of head & neck squamous cell carcinoma and pancreatic adenocarcinoma

Shengliang Zhang, Vida Tajiknia, Jillian Strandberg, 2024, bioRxiv.